Galaxy Surfactants Ltd. · NSE:GALAXYSURF
Galaxy Surfactants — Q1 FY27 Earnings Presentation
14 slides from Galaxy Surfactants's earnings presentation, Aug 13, 2026
Slide 1: Exchange cover letter for investor presentation
~ GALAXY Chemistry Creates Care August 13, 2026 National Stock Exchange of India Limited BSE Limited, Exchange Plaza, C-1, Block G, Listing Department, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, subBandra (East) Dalal Street, Mumbai – 400 051 Mumbai- 400001 Scrip Symbol: GALAXYSURF Scrip Code:
Slide 2: Galaxy Surfactants Limited Result Presentation August'26
~GALAXY Galaxy Surfactants Limited Result Presentation August’26 Chemistry Creates ::ire
Slide 3: Safe Harbor
Safe Harbor ~ GALAXY Chemistry Creates Care This presentation and the accompanying slides (the “Presentation”), which have been prepared by Galaxy Surfactants Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to
Slide 4: Company at a Glance
Company at a Glance ~ GALAXY Chemistry Creates Care Extensive R&D Capabilities 7 Strategically Located 215+ Product Grades Facilities with Inhouse 100+ Members Project Execution Capabilities Performance Surfactants: 47+ R&D Centre Specialty Care Products: 168+ Pilot Plant 5 in India Product Applicat
Slide 5: Q1FY27 Performance Highlights
Q1FY27 Performance Highlights
Slide 6: Management Commentary
Management Commentary ~ GALAXY Chemistry Creates Care “I am pleased that the strategic foundations we have been building over the years have translated into tangible outcomes. Our ability to anticipate risks, manage volatility, make disciplined commercial decisions and leverage a diversified portfol
Slide 7: Key Developments
Key Developments ~ GALAXY Chemistry Creates Care Consolidated volume growth in the mid-single digits, with a balanced contribution from both Performance Surfactants and Specialty Care Strong earnings recovery, with EBITDA growing 87% YoY to ₹252 Cr and EBITDA/MT improving to ₹35,458/MT, driven by di
Slide 8: Segment Performance Highlights: Q1FY27
Segment Performance Highlights: Q1FY27 ~ GALAXY Chemistry Creates Care Performance Surfactants Revenue Specialty Care Revenue Total Revenue ₹ 1,178.7 cr ₹ 603.2 cr ₹ 1,781.9 cr c ) c ) Volume Summary Category Performance Surfactant Mid Single Digit Growth Overall Mid Specialty Care Mid Single Digit
Slide 9: Consolidated Performance: Q1FY27
Consolidated Performance: Q1FY27 ~ GALAXY Chemistry Creates Care Rs in cr Total Revenue EBITDA PAT +38% +87% +109% 1,785 253 166 1,289 1,315 135 122 79 62 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Chemistry Creates Care 8
Slide 10: Revenue Performance: Q1FY27
Revenue Performance: Q1FY27 ~ GALAXY Chemistry Creates Care Category Customer Region wise Revenue 49% 44% 43% 54% 65% 66% 9% 22% 21% 7% 42% 39% 36% 35% 34% 34% Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 • Performance Surfactants Specialty Care Products • MNC Customer Regional Players • Local & Niche
Slide 11: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement ~ GALAXY Chemistry Creates Care Particulars (Rs. In Crores) Q1FY27 Q1FY26 Y-o-Y Q4FY26 Q-o-Q FY26 Net Revenue from Operations 1,781.9 1,277.9 39.4% 1,314.7 35.5% 5,248.3 Other Income 3.3 11.2 0.3 22.1 Total Revenue 1,785.2 1,289.2 38.5% 1,315.0 35.8% 5,270.4 Cost
Slide 12: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement ~ GALAXY Chemistry Creates Care Particulars (Rs. In Crores) Q1FY27 Q1FY26 Y-o-Y Q4FY26 Q-o-Q FY26 Net Revenue from Operations 1,265.5 874.1 44.8% 928.3 36.3% 3,589.1 Other Income 6.8 6.5 6.2 29.6 .' .' .' .' Total Revenue ' 1,272.3 ' 880.6 44.5% 934.5 36.1% 3,618.7
Slide 13: Managing Volatility in Raw Material Prices and Currency
Managing Volatility in Raw Material Prices and Currency... ~ GALAXY Chemistry Creates Care Fatty Alcohol Prices (USD / MT) INR / USD Prices LA Price USDINR 3,000 94.00 90.00 2,600 86.00 2,200 82.00 1,800 78.00 1,400 74.00 1,000 70.00 LA Price - USDINR … through Robust Risk Management Practices Chemi
Slide 14: Thank You
Thank You Company Investor Relations Advisors : ~ GALAXY SGA Strategic Growth Advisors Chemistry Creates Care CIN - U74140MH2010PTC204285 CIN No: L39877MH1986PLC039877 Mr. Mandar Chavan / Mr. Rahul Agarwal Mr. Ruchir Soni mandar.chavan@sgapl.net / Email: Ruchir.Soni@galaxysurfactants.com rahul.agarw